Cart
sales@molnova.com
Insecticidal agent 364
CAS No. 556055-08-4
Insecticidal agent 364( —— )
Catalog No. M36074 CAS No. 556055-08-4
Insecticidal agent 364 is a selective small molecule inhibitor of rapamycin kinase target protein.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | Get Quote |
|
| 10MG | 61 | Get Quote |
|
| 25MG | 119 | Get Quote |
|
| 50MG | 178 | Get Quote |
|
| 100MG | 257 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameInsecticidal agent 364
-
NoteResearch use only, not for human use.
-
Brief DescriptionInsecticidal agent 364 is a selective small molecule inhibitor of rapamycin kinase target protein.
-
DescriptionInsecticidal agent 364 is a selective small molecule inhibitor of rapamycin kinase target protein. Insecticidal agent 364 has antitumor activity, and by inhibiting mTOR, Insecticidal agent 364 aims to disrupt signaling pathways involved in cancer cell growth and survival, thereby potentially inhibiting tumor growth.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy | mTOR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number556055-08-4
-
Formula Weight430.48
-
Molecular FormulaC23H18N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(CC(=O)C=1C=C2C(=CC1)OCCO2)C=3N(C(=NN3)C=4C=CN=CC4)C5=CC=CC=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CA-5f
CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
-
GW406108X (b)
GW406108X(Z/E) is a mixture of different configurations of GW406108X, which is an inhibitor of Kinesin-12 and ULK1 .
-
LYN-1604 2HCl 221675...
LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604, to be the best candidate for a ULK1 agonist.?LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.
